282721-32-8

Basic information

• Product Name: Formamide, N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-
• Synonyms: Formamide,N-[2-(4-hydroxy-3-methoxyphenyl)ethyl];N2-(3-methoxy-4-hydroxyphenyl)ethylformamide;N-[2-(4-hydroxy-3-methoxy-phenyl)-ethyl]-formamide;N-Formyl-3-methoxy-4-hydroxy-phenaethylamin
• CAS NO: 282721-32-8
• Molecular Formula: C10H13NO3
• Molecular Weight: 195.21500
• Mol File: 282721-32-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Formamide, N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Formamide, N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-(282721-32-8)
• EPA Substance Registry System: Formamide, N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-(282721-32-8)

Safety Data

• Hazardous Substances Data: 282721-32-8(Hazardous Substances Data)

Upstream product

• 107-31-3 Methyl formate 
• 94066-84-9 3-Methoxy-4-tosyloxy-phenaethylamin 
• 22568-51-0 (E)-2-methoxy-4-(2-nitrovinyl)phenol 
• 109-94-4 formic acid ethyl ester 
• 87745-55-9 4-O-benzyl-N-benzyloxycarbonyldopamine 
• 37034-22-3 N-benzyloxycarbonyl-3,4-dihydroxyphenylethylamine 
• 51-61-6 dopamine 
• 528594-30-1 2-methoxy-4-(2-nitroethyl)phenol 
• 4468-59-1 4-hydroxy-3-methoxyphenylacetonitrile 
• 498-00-0 4-hydroxymethyl-2-methoxyphenol 
• 1477-68-5 3-Methoxytyramine hydrochloride 
• 149-73-5 trimethyl orthoformate 
• 64-18-6 formic acid 
• 554-52-9 3-Methoxytyramine 

Downstream Products

• 4602-73-7 3,4-dihydro-7-hydroxy-6-methoxy-isoquinoline 
• 282720-95-0 N-[2-(3-methoxy-4-pent-2-ynyloxy-phenyl)-ethyl]-formamide 
• 674773-25-2 2-amino-N-[2-(3-methoxy-4-(prop-2-ynyloxy)phenyl)ethyl]-2-p-tolylacetamide 
• 637359-33-2 4-(2-isocyanoethyl)-2-methoxy-1-(prop-2-ynyloxy)benzene 
• 374728-19-5 N-[2-(3-methoxy-4-(prop-2-ynyloxy)phenyl)ethyl]formamide 
• 32602-66-7 4-Hydroxy-3-methoxy-N-methylphenethylamine 

Relevant articles and documents

-

-

Syntheses of NAMDA derivatives inhibiting NO production in BV-2 cells stimulated with lipopolysaccharide

Sixteen derivatives of N-acetyl-3-O-methyldopamine (NAMDA), an inhibitor of BH4 synthesis, were designed and synthesized. The ability of these derivatives to inhibit NO and BH4 production by lipopolysaccharide- stimulated BV-2 microglial cells was determined. While NAMDA at 100 μM inhibited NO and BH4 production by only about 20%, its catecholamide 8, indole 23 derivative, 13, and N-acetyl tetrahydroisoquinoline 25 inhibited the NO production by >50% at the same concentration. In particular, 13 and 25 inhibited both NO and BH4 production to similar degrees, which suggested that these compounds might inhibit NO production by blocking BH 4-dependent dimerization of the newly synthesized iNOS monomer.

α-sulfenimino acid derivatives

α-Sulfenimino acid derivatives of formula I including the optical isomers thereof and mixtures of such isomers, wherein A is cycloalkyl, cycloalkenyl, aryl or heteroaryl, each optionally substituted, B is a direct bond or optionally substituted alkylene,